Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9459079 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL6359410 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL9459074 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL3932099 | 0.85 | ALDH1A1 (0.53) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL2064880 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL3142106 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL1666014 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL1665641 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL1665924 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TSHRPOLBCYP2C19MEN1 | |
| SCHEMBL5632186 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TSHRPOLBCYP2C19MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2043995-B1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2013-01-02 | — | — | EP | disclosed |
| US-8071824-B2 | Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position | BAYER CROPSCIENCE AG (DE) | 2011-12-06 | — | — | US | disclosed |
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | BAYER CROPSCIENCE AG (DE) | 2010-03-25 | — | — | US | disclosed |
| EP-2043995-A1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | Bayer CropScience AG (DE) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008006576-A1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | CYP1B1, AKR7A2, CYP1A1 | ALDH1A1 329/4885TSHR 3365/4885POLB 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.